Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 6/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GRK2 | P25098 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16971017 | 0.96 | TSHR (0.42) | BBOX1TSHRHPGDALDH1A1CYP3A4 | |
| SCHEMBL35503 | 0.94 | TSHR (0.47) | BBOX1TSHRHPGDALDH1A1CYP3A4 | |
| SCHEMBL16799372 | 0.93 | TSHR (0.50) | BBOX1TSHRHPGDALDH1A1CYP3A4 | |
| SCHEMBL16799079 | 0.92 | TSHR (0.53) | BBOX1TSHRHPGDALDH1A1CYP3A4 | |
| SCHEMBL16798999 | 0.92 | TSHR (0.53) | BBOX1TSHRHPGDALDH1A1CYP3A4 | |
| SCHEMBL16799087 | 0.92 | TSHR (0.53) | BBOX1TSHRHPGDALDH1A1CYP3A4 | |
| SCHEMBL16798995 | 0.92 | TSHR (0.53) | BBOX1TSHRHPGDALDH1A1CYP3A4 | |
| SCHEMBL18151644 | 0.92 | TSHR (0.53) | BBOX1TSHRHPGDALDH1A1CYP3A4 | |
| SCHEMBL15391248 | 0.91 | TSHR (0.42) | BBOX1TSHRHPGDALDH1A1CYP3A4 | |
| SCHEMBL16799249 | 0.89 | TSHR (0.49) | BBOX1TSHRHPGDALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025065051-A1 | PLASMA-MEDIATED POLYMER GRAFTING METHODOLOGY | THE UNIVERSITY OF SYDNEY (AU) | 2025-04-03 | — | — | WO | claimed |
| EP-4520795-A1 | ANTIFOULING MEMBER, MEMBER FOR IN-VITRO DIAGNOSTIC APPARATUS, AND METHOD OF PRODUCING ANTIFOULING MEMBER | CANON KABUSHIKI KAISHA (JP) | 2025-03-12 | — | — | EP | claimed |
| US-20250075095-A1 | ANTIFOULING MEMBER, MEMBER FOR IN-VITRO DIAGNOSTIC APPARATUS, AND METHOD OF PRODUCING ANTIFOULING MEMBER | CANON KABUSHIKI KAISHA (JP) | 2025-03-06 | — | — | US | claimed |
| WO-2023089167-A1 | PHOTOBIOREACTOR WITH AN ADSORBED LAYER OF ANTIFOULING ZWITTERIONIC COPOLYMER | FACELLITATE GMBH (DE) | 2023-05-25 | — | — | WO | claimed |
| US-11535588-B2 | Hydrated crystalline form of 2-acrylamido-2-methylpropane sulfonic acid | SPCM SA (FR) | 2022-12-27 | — | — | US | claimed |
| US-20220289672-A1 | HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULFONIC ACID | SPCM SA (FR) | 2022-09-15 | — | — | US | claimed |
| CN-114933673-A | Constant-current variable-flow type regulator based on polyacrylamide-butyl acrylate-zwitterion and preparation method thereof | 中海石油(中国)有限公司 | 2022-08-23 | — | — | CN | claimed |
| CN-103724557-B | A kind of preparation method of ultra early-strength polycarboxylic admixture | Jiangsu Subute New Materials Co., Ltd. (CN) | 2016-05-11 | — | — | CN | claimed |
| CN-103724557-A | Preparation method for super early-strength type poly carboxylic acid admixture | JIANGSU SUBOTE NEW MAT CO LTD | 2014-04-16 | — | — | CN | claimed |
| WO-2026099154-A1 | ADHESIVE DEVICE WITH HIGH BONDING STRENGTH | TESA SE (DE) | 2026-05-15 | — | — | WO | disclosed |
| WO-2026099181-A1 | DEVICE CAPABLE OF STAIN-FREE DEBONDING ON DEMAND | TESA SE (DE) | 2026-05-15 | — | — | WO | disclosed |
| WO-2026099184-A1 | ANTI-CORROSION ADHESIVE DEVICE | TESA SE (DE) | 2026-05-15 | — | — | WO | disclosed |
| EP-4739839-A1 | DIALDEHYDE POLYMER PRODUCTION PROCESS | SNF Group (FR) | 2026-05-13 | — | — | EP | disclosed |
| EP-4737529-A1 | ADHESIVE COMPOSITION, ADHESIVE TAPE AND THE USE THEREOF, AND METHOD FOR ELECTRICALLY MODIFYING THE ADHESIVE STRENGTH OF THE ADHESIVE TAPE | TESA SE (DE) | 2026-05-06 | — | — | EP | disclosed |
| US-20120074064-A1 | MEMBRANES HAVING IMPROVED PERFORMANCE | GAMBRO LUNDIA AB (SE) | 2012-03-29 | — | — | US | disclosed |
| EP-2253369-B1 | Membranes having improved performance | GAMBRO LUNDIA AB (SE) | 2011-11-09 | — | — | EP | disclosed |
| WO-2010133615-A1 | MEMBRANES HAVING IMPROVED PERFORMANCE | GAMBRO LUNDIA AB (SE) | 2010-11-25 | — | — | WO | disclosed |
| WO-2010133613-A1 | MEMBRANES HAVING IMPROVED PERFORMANCE | GAMBRO LUNDIA AB (SE) | 2010-11-25 | — | — | WO | disclosed |
| EP-2253367-A1 | Membranes having improved performance | Gambro Lundia AB (SE) | 2010-11-24 | — | — | EP | disclosed |
| EP-2253369-A1 | Membranes having improved performance | Gambro Lundia AB (SE) | 2010-11-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220289672-A1 | HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULFONIC ACID | SFN, H1-2, H1-0 | BBOX1 4421/4885TSHR 3902/4885HPGD 3814/4885 |
| US-11535588-B2 | Hydrated crystalline form of 2-acrylamido-2-methylpropane sulfonic acid | SFN, H1-2, H1-0 | BBOX1 4421/4885TSHR 3902/4885HPGD 3814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.